← Open Payments lookup

DAL SPERAZZA: Open Payments

NPI 1487685624 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$693 in 43 payments from 11 companies in 2025. Trend: 2023 $80 · 2024 $161 · 2025 $693

Food & beverage: $693
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$162
Neurocrine BioSciences, Inc.6$97
Janssen Pharmaceuticals, Inc4$75
Vanda Pharmaceuticals Inc.3$68
E.R. Squibb & Sons, L.L.C.4$58
Alkermes, Inc.3$53
ABBVIE INC.3$52
Corium, LLC3$39
Novo Nordisk Inc2$39
Teva Pharmaceuticals USA, Inc.2$33

Products named: CAPLYTA, INGREZZA, FANAPT, SPRAVATO, COBENFY, ARISTADA, VRAYLAR, Azstarys.

Industry payments across PA — which companies pay providers there.